Pathogenesis of Anti-PIT-1 Antibody Syndrome: PIT-1 Presentation by HLA Class I on Anterior Pituitary Cells

Overview

Journal J Endocr Soc

Specialty Endocrinology

Date 2019 Oct 18

PMID 31620667

Citations 8

Authors

Keitaro Kanie

Hironori Bando

Genzo Iguchi

Keiko Muguruma

Ryusaku Matsumoto

Ryoko Hidaka-Takeno

Yasuhiko Okimura

Masaaki Yamamoto

Yasunori Fujita

Hidenori Fukuoka

Kenichi Yoshida

Kentaro Suda

Hitoshi Nishizawa

Wataru Ogawa

Yutaka Takahashi

Affiliations

Soon will be listed here.

Abstract

Context: Anti-pituitary-specific transcriptional factor-1 (anti-PIT-1) antibody syndrome is characterized by acquired and specific deficiencies in growth hormone, prolactin, and thyroid-stimulating hormone. Although PIT-1-reactive cytotoxic T lymphocytes (CTLs) have been speculated to recognize anterior pituitary cells and to cause the injury in the pathogenesis of the syndrome, it remains unclear whether endogenous PIT-1 protein is processed through the proteolytic pathway and presented as an antigen on anterior pituitary cells.

Objective: To examine how PIT-1 protein is processed and whether its epitope is presented by major histocompatibility complex (MHC)/HLA class I on anterior pituitary cells.

Materials And Methods: Immunofluorescence staining and proximity ligation assay (PLA) were performed using anti-PIT-1 antibody and patients' sera on PIT-1-expressing cell line GH3 cells and human induced pluripotent stem cell (iPSC)-derived pituitary tissues.

Results: PIT-1 was colocalized with MHC class I molecules, calnexin, and GM130 in the cytosol. PLA results showed that PIT-1 epitope was presented by MHC/HLA class I molecules on the cell surface of GH3 cells and iPSC-derived pituitary cells. The number of PIT-1/HLA complexes on the cell surface of pituitary cells in the patient was comparable with that in the control subject.

Conclusions: Our data indicate that PIT-1 protein is processed in the antigen presentation pathway and that its epitopes are presented by in MHC/HLA class I on anterior pituitary cells, supporting the hypothesis that PIT-1-reactive CTLs caused the cell-specific damage. It is also suggested that number of epitope presentation was not associated with the pathogenesis of anti-PIT-1 antibody syndrome.

Citing Articles

Recapitulation and investigation of human brain development with neural organoids.

Tamada A, Muguruma K IBRO Neurosci Rep. 2024; 16:106-117.

PMID: 39007085 PMC: 11240300. DOI: 10.1016/j.ibneur.2023.12.006.

Organoid models of the pituitary gland in health and disease.

Laporte E, Vankelecom H Front Endocrinol (Lausanne). 2023; 14:1233714.

PMID: 37614709 PMC: 10442803. DOI: 10.3389/fendo.2023.1233714.

Disease Modeling of Pituitary Adenoma Using Human Pluripotent Stem Cells.

Matsumoto R, Suga H, Arima H, Yamamoto T Cancers (Basel). 2022; 14(15).

PMID: 35954322 PMC: 9367606. DOI: 10.3390/cancers14153660.

Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.

Kanie K, Iguchi G, Bando H, Urai S, Shichi H, Fujita Y Cancer Immunol Immunother. 2021; 70(12):3669-3677.

PMID: 33977343 PMC: 8571153. DOI: 10.1007/s00262-021-02955-y.

Pituitary Remodeling Throughout Life: Are Resident Stem Cells Involved?.

Laporte E, Vennekens A, Vankelecom H Front Endocrinol (Lausanne). 2021; 11:604519.

PMID: 33584539 PMC: 7879485. DOI: 10.3389/fendo.2020.604519.

References

Yamamoto M, Iguchi G, Takeno R, Okimura Y, Sano T, Takahashi M . Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest. 2010; 121(1):113-9. PMC: 3007153. DOI: 10.1172/JCI44073. View

Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A . An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells. 2012; 31(3):458-66. DOI: 10.1002/stem.1293. View

RICHTSMEIER A, Henry R, BLOODWORTH Jr J, EHRLICH E . Lymphoid hypophysitis with selective adrenocorticotropic hormone deficiency. Arch Intern Med. 1980; 140(9):1243-5. View

Bando H, Iguchi G, Fukuoka H, Yamamoto M, Hidaka-Takeno R, Okimura Y . Involvement of PIT-1-reactive cytotoxic T lymphocytes in anti-PIT-1 antibody syndrome. J Clin Endocrinol Metab. 2014; 99(9):E1744-9. DOI: 10.1210/jc.2014-1769. View

Daar A, Fuggle S, Fabre J, Ting A, Morris P . The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation. 1984; 38(3):287-92. DOI: 10.1097/00007890-198409000-00018. View

McMahon A, Bradley A . The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell. 1990; 62(6):1073-85. DOI: 10.1016/0092-8674(90)90385-r. View

Hannon M, OHalloran D . Isolated acquired ACTH deficiency and primary hypothyroidism: a short series and review. Pituitary. 2008; 14(4):358-61. DOI: 10.1007/s11102-008-0164-9. View

Khan U, Ghazanfar H . T Lymphocytes and Autoimmunity. Int Rev Cell Mol Biol. 2018; 341:125-168. DOI: 10.1016/bs.ircmb.2018.05.008. View

Bando H, Iguchi G, Okimura Y, Odake Y, Yoshida K, Matsumoto R . A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome. Sci Rep. 2017; 7:43060. PMC: 5316939. DOI: 10.1038/srep43060. View

10.

Wataya T, Ando S, Muguruma K, Ikeda H, Watanabe K, Eiraku M . Minimization of exogenous signals in ES cell culture induces rostral hypothalamic differentiation. Proc Natl Acad Sci U S A. 2008; 105(33):11796-801. PMC: 2575295. DOI: 10.1073/pnas.0803078105. View

11.

Lankat-Buttgereit B, Tampe R . The transporter associated with antigen processing: function and implications in human diseases. Physiol Rev. 2002; 82(1):187-204. DOI: 10.1152/physrev.00025.2001. View

12.

De Bellis A, Pane E, Bellastella G, Sinisi A, Colella C, Giordano R . Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism. Clin Endocrinol (Oxf). 2011; 75(3):361-6. DOI: 10.1111/j.1365-2265.2011.04056.x. View

13.

Jin H, Arase N, Hirayasu K, Kohyama M, Suenaga T, Saito F . Autoantibodies to IgG/HLA class II complexes are associated with rheumatoid arthritis susceptibility. Proc Natl Acad Sci U S A. 2014; 111(10):3787-92. PMC: 3956152. DOI: 10.1073/pnas.1401105111. View

14.

Schubert U, Anton L, Gibbs J, Norbury C, Yewdell J, Bennink J . Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature. 2000; 404(6779):770-4. DOI: 10.1038/35008096. View

15.

Iguchi G, Bando H, Takahashi Y . A Novel Clinical Entity of Autoimmune Endocrinopathy: Anti-PIT-1 Antibody Syndrome. Front Horm Res. 2017; 48:76-83. DOI: 10.1159/000452907. View

16.

Pamer E, Cresswell P . Mechanisms of MHC class I--restricted antigen processing. Annu Rev Immunol. 1998; 16:323-58. DOI: 10.1146/annurev.immunol.16.1.323. View

17.

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View

18.

Ito T . Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Clin Dev Immunol. 2013; 2013:348546. PMC: 3789320. DOI: 10.1155/2013/348546. View

19.

Bancroft F, Levine L, TASHJIAN Jr A . Control of growth hormone production by a clonal strain of rat pituitary cells. Stimulation by hydrocortisone. J Cell Biol. 1969; 43(3):432-41. PMC: 2107805. DOI: 10.1083/jcb.43.3.432. View

20.

Culina S, Lalanne A, Afonso G, Cerosaletti K, Pinto S, Sebastiani G . Islet-reactive CD8 T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci Immunol. 2018; 3(20). PMC: 5874133. DOI: 10.1126/sciimmunol.aao4013. View